$NVCR
NovoCure Ltd
PRICE
$57.1 โผ-0.122%
Extented Hours
VOLUME
563,923
DAY RANGE
56.055 - 57.64
52 WEEK
56.055 - 120.03
Join Discuss about NVCR with like-minded investors
@dros #droscrew
Upgrades 1/3: $ALNY $AVB $BXP $CHRW $COO $CP $IIVI $MCD $NVCR $NVT $PNC $PYPL $REG $REGN $RF $RKT $SE $SEAT $SLG $UAL $WFC $WOLF . Downgrades 1/3: $ACC $ATUS $CAKE $CARR $CHTR $EXC $FTV $GMAB $HBAN $JBLU $KC $KIM $LUV $MMC $MPW $NAVI $QSR $ROST $SAVE $SYF $TT $USB
134 Replies 9 ๐ 14 ๐ฅ
@Benlax #droscrew
every one of these nicely green except veev at -.8% > @Benlax said: making more moves in the retirement acct I took over: z, veev, crowd, lrlcy, blk, meli, now, wms, adyey, syk, se, smg, nvcr, Twtr, axon, net, step, cost, ely, wix all new positions in order of size. I've held all the etfs for now (he has like 10 that almost all do the same thing) and that still makes up like 60%+ of the port
106 Replies 11 ๐ 7 ๐ฅ
@Benlax #droscrew
making more moves in the retirement acct I took over: z, veev, crowd, lrlcy, blk, meli, now, wms, adyey, syk, se, smg, nvcr, Twtr, axon, net, step, cost, ely, wix all new positions in order of size. I've held all the etfs for now (he has like 10 that almost all do the same thing) and that still makes up like 60%+ of the port
77 Replies 11 ๐ 10 ๐ฅ
@Benlax #droscrew
nari is great but had some high expectations priced in, same with nvcr
58 Replies 12 ๐ 13 ๐ฅ
@Benlax #droscrew
added back some of the NVCR shares I sold at 210. should've been more aggressive with trims above 200
144 Replies 8 ๐ 15 ๐ฅ
@Benlax #droscrew
sto single sept 220c on NVCR ahead of ER and sept 210/220c in non tier 3 acct. Also trimmed a few shares
71 Replies 9 ๐ 8 ๐ฅ
@Benlax #droscrew
veev the beast ripping green. nvda etsy wix nvcr okta tdoc pgny all turning up
131 Replies 13 ๐ 13 ๐ฅ
@Benlax #droscrew
china name highly tied to NVCR, both (china and nvcr) got whacked recently and zlab hasnt moved, likely going higher
78 Replies 8 ๐ 13 ๐ฅ
@Benlax #droscrew
wow sike, ripping premarket, only got one day > @Benlax said: wow buy off 140 wouldve been a snipe today, keep an eye if it gives up gains post NVCR news (they distribute in china) will be a good r/r
150 Replies 14 ๐ 10 ๐ฅ
Key Metrics
Market Cap
6.03 B
Beta
1.29
Avg. Volume
760.95 K
Shares Outstanding
105.46 M
Yield
0%
Public Float
0
Next Earnings Date
2023-04-27
Next Dividend Date
Company Information
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Tumor Treating Fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure's commercialized products are approved for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and liver cancer.
CEO: Asaf Danziger
Website: www.novocure.com
HQ: Forum No 4 Grenville Street, JE2 4UF Saint Helier
Related News